Memorial Sloan Kettering Cancer Center ( Site 0060)

New York, New York 10065

0 studies enrolling now · 2 studies all time

What they study most

Hodgkin Lymphoma, Non-small Cell Lung Cancer

Studies at this site

• Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) — Running, not enrolling
• Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) — Running, not enrolling